RHHBY Roche Holdings Ltd ADR

$0.00 (0.00%)

RHHBY Stock Analysis Overview

What this means: Roche Holdings Ltd ADR (RHHBY) gets an Overall Rank of 65, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. RHHBY's 65 means that it ranks higher than 65% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

Create a FREE account to see full RHHBY report

Roche Holdings Ltd ADR (RHHBY) Analyst Forecast

Next 12 months ➝Current Price$44.1352-week High$46.0052-week Low$32.67No Forecast Data Available for RHHBY
  • Last Price$44.13
  • Previous Close$44.13
  • Change $0.00
  • Open$44.61
  • Volume950,700
  • Avg. Volume (100-day)2,524,719
  • Market Capitalization$302B
  • Days Range $44.10 - $44.69
  • 52-week Range $32.67 - $46.00
  • Dividend Yield1.61%
  • Ex. Dividend Date03/19/2020
  • P-E22.3
  • EPS1.55
  • Earnings Date
  • SectorHealthcare
  • IndustryDrug Manufacturers - General
  • Avg. Analyst Rec.
  • Beta-0.127
  • PEG Ratio
  • Volatility0.17
  • Average True Range0.03
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 60% of pharmaceutical sales, and professional diagnostics for more than half of diagnostic-related sales.